For millions of women around the world, PCOS has long been a condition surrounded by confusion, delayed diagnoses and misunderstanding. Now, in a major step forward for women’s health, the condition is getting a new name — one that experts believe finally reflects what patients have been experiencing all along.
While the change may seem small at first glance, health experts say it represents a much deeper understanding of the condition. For years, many people believed PCOS was simply a problem involving ovarian cysts. In reality, it is a complex hormonal and metabolic disorder that can affect multiple systems in the body throughout a person’s life.
The decision comes after 14 years of international collaboration involving researchers, doctors, healthcare organisations and thousands of women living with the condition. The announcement was published in The Lancet and led by experts from Monash University alongside the International PCOS Network.
One of the biggest concerns with the old name was that it often misled both patients and healthcare professionals. Many women diagnosed with PCOS do not actually have ovarian cysts, and researchers say there is little evidence linking the condition to abnormal ovarian cyst formation in the first place. Because of this, the name failed to capture the full reality of the disorder.
PMOS is intended to better reflect the condition’s connection to hormone imbalance, metabolism and endocrine function. Symptoms can vary widely and may include irregular menstrual cycles, fertility challenges, acne, weight fluctuations, excessive hair growth, insulin resistance and even mental health struggles such as anxiety and depression.
Experts hope the new terminology will encourage earlier diagnosis and more holistic treatment. Despite affecting roughly one in eight women globally, awareness remains low, and many patients spend years searching for answers before receiving proper care.
Advocates say the previous focus on “ovaries” and “cysts” often caused the wider health implications to be overlooked. The new name aims to shift the conversation away from seeing the condition as only a reproductive issue and toward recognising it as a serious endocrine and metabolic health condition.
The renaming process involved 56 organisations worldwide, with more than 22,000 people contributing through surveys, consultations and workshops. Cultural sensitivity also played a major role, especially in regions where reproductive health discussions still carry stigma.
According to the experts behind the initiative, the transition from PCOS to PMOS will happen gradually over the next three years, supported by global awareness and education campaigns for healthcare workers, researchers and patients.
The updated name is expected to become fully integrated into international clinical guidelines by 2028, with many hoping it will lead to improved research funding, better healthcare support and fewer women being left unheard or undiagnosed.